Sphera Funds Management’s Freeline Therapeutics Holdings FRLN Stock Holding History
Bought
Maintained
Sold
Sphera Funds Management's FRLN Position: Q1 2024 in Review
Sphera Funds Management sold out of Freeline Therapeutics Holdings (FRLN) in Q1 2024, closing a stake of 16,445 shares — an estimated $105K sold.
Sphera Funds Management first reported a position in FRLN in Q4 2023 and held it in 1 quarter. The position peaked at $105K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.
- Sphera Funds Management reported no remaining Freeline Therapeutics Holdings position as of Q1 2024 after selling out during the quarter.
- Sphera Funds Management sold 16,445 Freeline Therapeutics Holdings shares in Q1 2024, an estimated $105K.
- Sphera Funds Management first reported a position in Freeline Therapeutics Holdings in Q4 2023 and held it in 1 quarter.
- Sphera Funds Management's Freeline Therapeutics Holdings position peaked at $105K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q1 2024.
Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.